2022
DOI: 10.1016/j.bioactmat.2022.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Translation of biomaterials from bench to clinic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 25 publications
0
10
0
Order By: Relevance
“…The development processes of products executed by companies (the right side of the dotted line in Fig. 2 ) need to follow the practice regulated by regulatory authorities [ 5 ]. Without getting the details of design control processes for the development of biomaterial products, the development process of biomaterials products can be categorized as stages of non-clinical and clinical evaluations.…”
Section: Biomaterials Researchmentioning
confidence: 99%
“…The development processes of products executed by companies (the right side of the dotted line in Fig. 2 ) need to follow the practice regulated by regulatory authorities [ 5 ]. Without getting the details of design control processes for the development of biomaterial products, the development process of biomaterials products can be categorized as stages of non-clinical and clinical evaluations.…”
Section: Biomaterials Researchmentioning
confidence: 99%
“…All medical devices must fulfill clinical needs and solve practical problems [ [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] ]. The academic value of research findings is not always aligned with their clinical values.…”
Section: A Regulatory Perspectivementioning
confidence: 99%
“…The academic value of research findings is not always aligned with their clinical values. However, if an innovation is expected to bring new technologies and products to the market, then research on market and clinical demands should be conducted as early as possible [ [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] ]. The urgent clinical needs and unsolved problems should be pinpointed to refine the research program accordingly.…”
Section: A Regulatory Perspectivementioning
confidence: 99%
See 1 more Smart Citation
“…The release of ions from the bioactive materials elicited an effect and increased the chances of regeneration and remineralization. Various studies have been conducted to assess the bioactive potential of biomaterials in the oral environment and evaluated their performances in multiple clinical applications [ 25 , 26 , 27 , 28 ]. The outcomes of these studies showed that the bioactive materials’ applications to enhance oral health were developing at a rapid pace.…”
Section: Introductionmentioning
confidence: 99%